PM360 Innovations 2022

PM360 2022 Innovative Product: PRECISIONscientia’s DOL Map

PRECISIONscientia’s DOL Map was named one of 2022’s Most Innovative Products in PM360‘s 11th Annual Innovations issue

DOL Map Network

HCPs look to thought leaders in specific medical fields for trusted advice and opinions. The continued growth of social and digital communications has ushered in new channels for the exchange of ideas and opinions. And now, these channels have given rise to new voices of influence—Digital Opinion Leaders (DOLs).


DOLs are important stakeholders for pharma marketers because of their inherent ability to educate and influence broad swaths of HCPs and patient followers through the DOLs’ preferred digital channels. To help pharma marketers identify and gain insights on DOLs in specific therapeutic areas, PRECISIONscientia has developed a powerful, web-based proprietary platform, DOL Map. The platform delivers an intuitive experience that summarizes each DOL’s impact, reach, and relevance to clients’ disease focus. DOL Map focuses on key components to find the right DOLs for any commercial brand or product in development: relevance, reach and audience engagement, impact on audience, and authenticity.

DOL Map aids in creating a data-driven strategy, the means to listen to and engage DOLs, and a measurable assessment of the impact of engagements to accelerate brand awareness. In one case study, a client sought to assess clinician awareness on digital platforms of an ultra-rare disease to better support patient identification efforts. The project resulted in 50 DOLs identified and profiled, analysis of 5,000+ discussions involving these DOLs over the past five years, and real-time data collected to measure the amplification of client’s recent clinical data readout which uncovered five new conversations about the research reaching 10,000+ followers within two days. With the PRECISIONscientia DOL Map, clients achieve their strategic goals of assessing online awareness and driving effective engagements with DOLs.

Contact Person:
Anuraag Sarangi, AVP, HCP Strategy & Insights


More information on KOL Data Solutions and DOL Map

DOL Map Case Study

The Precision Value & Health family of brands is now Precision AQ

Precision AQ helps life sciences companies navigate the complexities of commercialization across a product’s lifecycle. Our team is comprised of experts, advisors, and creators working to ensure patients have access to life-changing medicines.

Our global offerings include:

  • Commercialization research, strategy and product planning
  • HEOR
  • Market access
  • Advertising, Branding & PR
  • Medical communications
  • Investor relations and external communications
  • Learning & development
  • Data and product solutions (Access Genius, Navigator365, OncoGenius, EHR Solutions, KOL/DOL Map)

Our name, which stands for Precision Access Quotient, reflects our approach to removing barriers – fusing together science (IQ, or Intelligence Quotient) and empathy (EQ, or Emotional Quotient). The result is “AQ: Access Quotient”, a critical ingredient in navigating the therapy-to-patient journey informed by data-driven analytics and insights.

To find out more about our global services and our unified mission, empowering access to life-changing medicines for all, visit: Precision AQ


Accelerating clinical research and development through the combined power of trials, labs, and data science.

Demonstrating the value of life-science innovations with evidence and real-world expertise.